These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7770611)

  • 1. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats.
    Bosker FJ; van Esseveldt KE; Klompmakers AA; Westenberg HG
    Psychopharmacology (Berl); 1995 Feb; 117(3):358-63. PubMed ID: 7770611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
    Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function.
    Gonzalez LE; Parada MA; Tucci S; Teneud L; Overstreet DH; Hernandez L
    Braz J Med Biol Res; 2003 Feb; 36(2):263-7. PubMed ID: 12563529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
    Tokarski K; Bijak M
    Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis.
    Hjorth S; Auerbach SB
    Neuropharmacology; 1994; 33(3-4):331-4. PubMed ID: 7984270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
    Gur E; Lerer B; Newman ME
    J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram.
    Invernizzi R; Bramante M; Samanin R
    Brain Res; 1995 Oct; 696(1-2):62-6. PubMed ID: 8574685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat.
    Bosker FJ; Klompmakers AA; Westenberg HG
    Neuropharmacology; 1995 May; 34(5):501-8. PubMed ID: 7566484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
    Roberts C; Boyd DF; Middlemiss DN; Routledge C
    Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of (+/-)-pindolol over increased extracellular 5-HT level induced by fluvoxamine: regional difference in effect among the raphe, dorsal hippocampus and prefrontal cortex as measured by in vivo microdialysis technique].
    Nakada S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):51-60. PubMed ID: 11062862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
    Hjorth S
    Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.